Inequities in Access to Tricuspid Valve Treatments
Patients in higher socioeconomic deprivation areas travel longer distances to hospitals meeting procedure volume requirements. Policymakers and patient advocacy groups should consider this to ensure equitable access to potentially life-saving technologies.
Authors
- Sarah Mollenkopf (ORCID: https://orcid.org/0000-0001-9214-2492)
- Candace Gunnarsson (ORCID: https://orcid.org/0000-0003-0723-585X)
- Melissa Mancilla (ORCID: https://orcid.org/0009-0008-5758-420X)
- Colin M. Barker
- Guy David (ORCID: https://orcid.org/0000-0001-9191-741X)
- Michael T. Ryan (ORCID: https://orcid.org/0000-0003-2586-8829)
- Linda Kemp
Institutions
- Edwards Lifesciences (United States) (US)
- University of Pennsylvania (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101342
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- Edwards Lifesciences
- Boston Scientific Corporation